Electra Therapeutics, Inc. · NASDAQ:ETRA

Orbimed Advisors LLC bought 472,571 Electra Therapeutics, Inc. shares (Form 4)

Traded Nov 3 to Nov 5, 2026 · Filed Nov 5, 2026

From Nov 3 to Nov 5, 2026, Orbimed Advisors LLC (Director, 10% owner) bought 472,571 Electra Therapeutics, Inc. shares at an average US$7.63 for US$3.61M, leaving 2,136,979 shares. Filed Nov 5, 2026 (Form 4).

Bought
472,571 shares
Price
US$7.63 average (US$7.07 to US$7.88)
Value
US$3.61M
Holding after
2,136,979 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 3, 2026Common StockBuy24,313US$7.845,151,204Indirect
Nov 3, 2026Common StockBuy97,800US$7.841,856,079Indirect
Nov 3, 2026Common StockBuy24,400US$7.885,175,604Indirect
Nov 3, 2026Common StockBuy98,600US$7.881,954,679Indirect
Nov 4, 2026Common StockBuy9,267US$7.785,184,871Indirect
Nov 4, 2026Common StockBuy37,100US$7.781,991,779Indirect
Nov 4, 2026Common StockBuy5,000US$7.075,189,871Indirect
Nov 4, 2026Common StockBuy20,000US$7.072,011,779Indirect
Nov 5, 2026Common StockBuy30,891US$7.315,220,762Indirect
Nov 5, 2026Common StockBuy125,200US$7.312,136,979Indirect

Source

Download original · View original at SEC

Related